Matches in Wikidata for { <http://www.wikidata.org/entity/Q59271736> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q59271736 description "article by Julia Uceda et al published 2012 in Journal of Translational Medicine" @default.
- Q59271736 description "wetenschappelijk artikel" @default.
- Q59271736 description "наукова стаття, опублікована у 2012" @default.
- Q59271736 name "The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods" @default.
- Q59271736 name "The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods" @default.
- Q59271736 type Item @default.
- Q59271736 label "The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods" @default.
- Q59271736 label "The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods" @default.
- Q59271736 prefLabel "The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods" @default.
- Q59271736 prefLabel "The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods" @default.
- Q59271736 P1433 Q59271736-727F1AFE-A2EB-44A8-8F3A-777715F66B60 @default.
- Q59271736 P1476 Q59271736-638B14B2-C5AA-4C52-A67B-BE44DD0D84FA @default.
- Q59271736 P2093 Q59271736-0E842859-6A33-44D5-AD38-FA7E1C339A6C @default.
- Q59271736 P2093 Q59271736-8AAF497C-7A4D-4079-84C1-847F21D6B304 @default.
- Q59271736 P2093 Q59271736-CB52A32F-AC35-4ACE-9EEA-1AB6182EAC00 @default.
- Q59271736 P2093 Q59271736-E18C0757-0722-40C8-86FA-A00CF440231E @default.
- Q59271736 P275 Q59271736-afdefb02-7451-4b8c-9b85-cec58566742f @default.
- Q59271736 P2888 Q59271736-7CE44E37-0F6F-4C13-BED8-7758DD4D5119 @default.
- Q59271736 P304 Q59271736-2F819BEC-9271-4AD1-B7A1-8AA713372276 @default.
- Q59271736 P31 Q59271736-F7E2FACE-2C0A-411E-9621-BB771D219024 @default.
- Q59271736 P356 Q59271736-388CDCCC-864E-40C3-A875-17381190B545 @default.
- Q59271736 P433 Q59271736-C27A6ADE-5C20-4D2E-9639-1FDA7B865E1F @default.
- Q59271736 P478 Q59271736-1E304A4C-F24D-4863-8D73-FAC82D8269BB @default.
- Q59271736 P577 Q59271736-72B7DBF7-6349-4240-A467-1C9FCE3C97E9 @default.
- Q59271736 P6179 Q59271736-3C7AFAD8-84E0-4931-B8EF-394ED642A1AD @default.
- Q59271736 P6216 Q59271736-da3e34d9-fd92-4e7f-a105-d20da699b42f @default.
- Q59271736 P932 Q59271736-13146599-AF59-452E-A129-66A27454E4C8 @default.
- Q59271736 P356 1479-5876-10-S3-P28 @default.
- Q59271736 P1433 Q15716664 @default.
- Q59271736 P1476 "The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods" @default.
- Q59271736 P2093 "Alejandro Muñoz" @default.
- Q59271736 P2093 "Jose L Marenco" @default.
- Q59271736 P2093 "Julia Uceda" @default.
- Q59271736 P2093 "Loreto Carmona" @default.
- Q59271736 P275 Q19125117 @default.
- Q59271736 P2888 1479-5876-10-s3-p28 @default.
- Q59271736 P304 "P28" @default.
- Q59271736 P31 Q13442814 @default.
- Q59271736 P356 "10.1186/1479-5876-10-S3-P28" @default.
- Q59271736 P433 "Suppl 3" @default.
- Q59271736 P478 "10" @default.
- Q59271736 P577 "2012-01-01T00:00:00Z" @default.
- Q59271736 P6179 "1039813246" @default.
- Q59271736 P6216 Q50423863 @default.
- Q59271736 P932 "3509079" @default.